*Tech adviser cites dramatic improvement since Oct. 1. Dec 1- Two months after the disastrous launch of a website that is a key component of President Barack Obama's healthcare law, administration officials said on Sunday they had met their goal of getting the HealthCare.gov site running smoothly but warned that it needs more fixes.» Read More
Though the U.S. had made much progress taking medical record keeping into the digital age, there's still some doubt that the government will reach its target by the prescribed deadline.
The federal government has received a surge in complaints in recent months about failed hip replacements, suggesting that serious problems persist with some types of artificial hips even as researchers scramble to evaluate the health dangers. The New York Times reports.
Blood-testing equipment maker Immucor says it agreed to be acquired by TPG Capital in a deal worth $1.97 billion, or $27 per share in cash.
Ranking No. 1 for the 5th year running, California surpassed even its own 2010 performance. Yet, tech-savvy runners-up to the Silicon Valley state aren’t that far behind.
Biotech is projected to expand at an annual rate of 1.5%. A look at innovation and growth in the industry, with Jim Greenwood, Biotechnology Industry Organization president/CEO.
Making a case for lap-band surgery and discussing the benefits to patients and insurance companies, with David Pyott, Allergan CEO.
A new test developed by a unit of biotech company Life Technologies has shown success in quickly pinpointing the strain of E. coli involved in a European outbreak that has killed 25 people and sickened more than 2,400 worldwide.
While growing computing demand will mean more energy consumption, wider use of cloud computing technology will prove to be a net benefit to the environment over the longer term, say industry watchers.
Rep. Ron Paul (R-TX) outlines his bid for US president. "Why have we given up on the free market?" he says. "What we're doing is destroying the purchasing power of the dollar."
Medtronic, the world's largest medical device maker, says its fourth-quarter net income dropped 19 percent on expenses related to its recent layoffs.
The Centers for Disease Control considers obesity in America an epidemic; more than one out of three adults and 17 percent of all children are technically overweight to the point of obesity.
Spending a month in China earlier this year left me with a clear picture of a nation of rapid change, vast scale, and stark contrasts. All of these factors create opportunities – and challenges – for American businesses in China, and particularly for those of us in health care.
Personalized medicine has finally arrived and is poised to deliver significant health improvement and healthcare cost savings.
The government is making an increasing number of expensive life-saving or life extending drugs and devices available to more people, but is that the right thing to do and can we afford it, anyway?
Health care is an emotional subject for many Americans — and often one of extremes. Yet, as we obssess about the system's structure and cost, we neglect our own health. Obesity and high blood pressure are more common, while exercise and diet are overlooked. Our special report, "Healthy Business", explores these issues.
More and more American women are seeking infertility treatment to increase their chances of having a child, but there's been no change in success rates and costs remain high, even with health insurance coverage.
Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector: large-cap pharmaceutical stocks.
Manufacturers are delivering an ever growing roster of exercise games and interactive fitness technology to health clubs, YMCAs, park, recreation centers and even schools.
Among the crowded ranks of healthy food trends -- quinoa, farm-to-table, whole whole grains — one food category is growing into a genuine, industry juggernaut: gluten-free.
Health-conscious U.S. consumers are buying hundreds of millions of dollars of so-called superfruits annually, even as critics contend their nutritional benefits are overblown and, in some cases, nonexistent.